Related Experiment Video
Updated: Nov 29, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
STAT3 regulates miR93-mediated apoptosis through inhibiting DAPK1 in renal cell carcinoma
1Department of Urology, First Hospital of China Medical University, 110001, Shenyang, China.
Abstract:
Signal transducer and activator of transcription 3 (STAT3) is an essential member of the STAT family. STAT3 regulates diverse genes that mediate inflammatory reactions, cell survival, proliferation, and angiogenesis, and it is aberrantly upregulated and activated in various types of malignancies. Furthermore, STAT3 signalling is involved in multiple feedback loops and pathways. In this study, we demonstrate that miR-93-3p plays an oncogenic role in renal cell carcinoma (RCC) by enhancing RCC cell proliferation and suppressing apoptosis. In addition, STAT3 can regulate the transcription of miR-93 by directly binding its promoter region. miR-93 can inhibit death-associated protein kinase 1 (DAPK1) at the protein level. Moreover, STAT3 can block DAPK1 expression at the RNA level. Importantly, we verified that DAPK1 overexpression in turn suppresses the entry of activated STAT3 into the cell nucleus. Thus, this study reveals a potential continuously activated signalling transduction pathway, STAT3-miR93-DAPK1, and may provide a novel clinical therapeutic approach for RCC.
Insights
Signal transducer and activator of transcription 3 (STAT3) promotes renal cell carcinoma (RCC) by upregulating miR-93, which inhibits DAPK1. This STAT3-miR93-DAPK1 pathway offers a potential therapeutic target for RCC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Signal transducer and activator of transcription 3 (STAT3) is crucial in regulating inflammatory responses, cell survival, proliferation, and angiogenesis.
- Aberrant STAT3 activation is implicated in various cancers, including renal cell carcinoma (RCC).
- STAT3 signaling pathways are complex and involve multiple feedback loops.
Purpose of the Study:
- To investigate the role of miR-93-3p in renal cell carcinoma (RCC).
- To elucidate the regulatory relationship between STAT3, miR-93, and death-associated protein kinase 1 (DAPK1) in RCC.
- To identify a potential therapeutic pathway for RCC.
Main Methods:
- Investigated the function of miR-93-3p in RCC cell proliferation and apoptosis.
- Analyzed the transcriptional regulation of miR-93 by STAT3.
- Examined the inhibitory effect of miR-93 on DAPK1 expression.
- Assessed the impact of DAPK1 on STAT3 nuclear translocation.
Main Results:
- miR-93-3p enhances RCC cell proliferation and suppresses apoptosis, indicating an oncogenic role.
- STAT3 directly regulates miR-93 transcription.
- miR-93 inhibits DAPK1 protein expression, and STAT3 further suppresses DAPK1 at the RNA level.
- Overexpressed DAPK1 inhibits activated STAT3 nuclear entry.
Conclusions:
- A novel STAT3-miR93-DAPK1 signaling pathway was identified in RCC.
- This pathway is continuously activated and contributes to RCC progression.
- The STAT3-miR93-DAPK1 axis represents a potential therapeutic target for RCC treatment.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
MicroRNAs

